VOLUME 64 2003 SUPPLEMENT 19
ARTICLES
3 Introduction. Ziprasidone in
Schizophrenia: From Acute Treatment
to Long-Term Management. John M.
Kane
[PDF]
6 The Psychopharmacology of Ziprasidone:
Receptor-Binding Properties and Real-World
Psychiatric Practice. Stephen M.
Stahl and Darius K. Shayegan
[Abstract]
[PDF]
13 Intramuscular Ziprasidone: Moving
Beyond the Conventional in the
Treatment of Acute Agitation in Schizophrenia. Shlomo Brook
[Abstract]
[PDF]
19 Oral Ziprasidone in the Treatment of
Schizophrenia: A Review of
Short-Term Trials. John M. Kane
[Abstract]
[PDF]
26 Maintaining Symptom Control: Review of Ziprasidone Long-Term Efficacy Data.
Nina R. Schooler
[Abstract]
[PDF]
33 Ziprasidone and Cognition: The
Evolving Story. Philip D. Harvey
[Abstract]
[PDF]
40 Tolerability of Ziprasidone: An
Expanding Perspective. David G.
Daniel
[Abstract]
[PDF]
|